The Global Market for Testosterone Replacement Therapy (2019-2023): Leading Players are AbbVie, Bayer and Endo Pharmaceuticals - ResearchAndMarkets.com
Thursday, 10 January 2019 03:06
Jan. 10, 2019 11:56 UTC

The Global Market for Testosterone Replacement Therapy (2019-2023): Leading Players are AbbVie, Bayer and Endo Pharmaceuticals - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)-- The "Global Testosterone Replacement Therapy Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The testosterone replacement therapy market growth at a CAGR of more than (2%) during the forecast period.

The latest trend gaining momentum in the market is due to availability of such patient assistance programs, individuals are inclined toward buying these drugs, thereby increasing the growth of the market.

According to the report, one of the major drivers for this market is the increasing awareness about hypogonadism among the public and primary care physicians will drive the market.

Further, the report states that one of the major factors hindering the growth of this market is the availability of generics in the market acts as a challenge of the growth of the market.

Key Players

  • AbbVie
  • Bayer
  • Endo Pharmaceuticals

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

PART 06: FIVE FORCES ANALYSIS

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Injections - Market size and forecast 2018-2023
  • Topicals - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie
  • Bayer
  • Endo Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/34dm3s/the_global_market?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs


Source: Research and Markets




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter